Understanding what causes ovarian cancer to come back after treatment
Identifying factors associated with ovarian cancer recurrence using a population-based approach
This study is looking at what causes ovarian cancer to come back after treatment, focusing on the genes and other markers that might help predict this, so that women with ovarian cancer can get better, more personalized care in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11211522 on NIH RePORTER |
What this research studies
This research investigates the factors that contribute to the recurrence of ovarian cancer after initial treatment. By analyzing gene expression signatures and other biological markers, the study aims to identify distinct characteristics of ovarian cancer that may predict the likelihood of recurrence. Patients who have been diagnosed with ovarian cancer will be the focus, as the research seeks to gather data from a diverse population to enhance the understanding of this disease. The findings could lead to improved prognostic tools and personalized treatment strategies for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have been diagnosed with ovarian cancer and are in remission after initial treatment.
Not a fit: Patients who have not been diagnosed with ovarian cancer or those who are currently undergoing treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better predictions of ovarian cancer recurrence, allowing for more tailored and effective treatment plans.
How similar studies have performed: Previous research has shown promise in using gene expression signatures to predict cancer outcomes, suggesting that this approach could yield valuable insights.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Collin, Lindsay Jane — Emory University
- Study coordinator: Collin, Lindsay Jane
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.